Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Within Subject, Placebo Controlled Randomised Trial to Investigate the Scar Improvement Efficacy of a Single Intradermal Application of RN1001 (Avotermin) in Female Subjects Undergoing Bilateral Breast Augmentation

NCT00436449 is registered in ClinicalTrials.gov with Renovo as lead sponsor.

NCT NCT00436449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00436449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Within Subject, Placebo Controlled Randomised Trial to Investigate the Scar Improvement Efficacy of a Single Intradermal Application of RN1001 (Avotermin) in Female Subjects Undergoing Bilateral Breast Augmentation
Lead sponsor
Renovo
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
January 31, 2008
Enrollment
63 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cicatrix, mammaplasty